Question to the Department for Business, Innovation, Science and Trade:

To ask the Secretary of State for Business, Innovation, Science and Trade, what steps the Intellectual Property Office is taking to consider the public harm associated with counterfeit medicines in developing its forthcoming Counter-Infringement Strategy.

The Intellectual Property Office recognises the public harm that can arise from IP crime and infringement, including counterfeit goods that often pose risks to health and safety.

In developing its future strategy, the IPO is working across government, law enforcement and industry to better understand these harms and how they can be minimised.